LinkedIn video ad examples

😯 Una caduta può cambiare tutto. Ci troviamo a Montechiarugolo nel terzo episodio della campagna “𝐓𝐫𝐚 𝐢𝐥 (𝐃)𝐢𝐫𝐞 𝐞 𝐢𝐥 𝐟𝐚𝐫𝐞” dove scopriamo la storia di Fiorella e papà Attilio: una brutta caduta, un femore rotto e il desiderio di tornare a camminare tra le vie del suo paese. Nel suo percorso di ripresa, insieme alla fisioterapia, vediamo che anche un corretto apporto di vitamina D può fare la differenza, supportando al meglio la salute delle ossa. Guarda la puntata completa sul canale Youtube di IBSA Italy 🖇️ #IBSA #IBSAItaly #CaringInnovation #VitaminaD

Not the Peep Show you were expecting... Whether it's the curtains opening or your eyelids, a pterygium can be an unwanted surprise. Find out more with the Cloudbreak Medical Affairs team, at the American Academy of Ophthalmology Annual Meeting in New Orleans. We look forward to seeing you there, booth 663. New Orleans Convention Center October 10 – 12, 2026 Pterygium overview: https://lnkd.in/g4NKTkcF We welcome conversations with people and organizations interested in our first-in-class multi-kinase inhibitor topical ophthalmic drug portfolio. To connect, please reach out to us at [email protected] #Ophthalmology #Biotech #ClinicalTrials #Pterygium #BiotechInvesting #LifeSciences #AAO2026 #AAO

📣 Major announcement: Endologix is now Rhevera Medical. A new identity for a company built around one purpose: preserving and restoring the blood flow that sustains life. Since its founding in 1992, Endologix has built its business in aortic repair and has since expanded across the vascular space. Rhevera Medical now reflects the full portfolio and where we are headed as a company. Welcome to what's next. 🔗 Read the official press release: https://lnkd.in/gPQJZnxF Rhevera Medical Holdings is the parent company of Endologix LLC. Endologix LLC is the legal manufacturer of the company's devices. #RheveraMedical #MedTech #VascularHealth #HealthInnovation

Dr. Anthony Estrera, Cardiothoracic Surgeon at UT Health, shares his observations on how the Arcevo ™ LSA device affects his approach to arch repair of the left subclavian artery. 👉 Discover more about the ARTIZEN Pivotal Trial of the Arcevo LSA device here: https://lnkd.in/eEr59kZF

Dr. Marijan Koprivanac, Cardiothoracic Surgeon at the Cleveland Clinic, shares his perspective on how the Arcevo™ LSA device will shape the approach to the frozen elephant trunk procedure for aortic arch repair. 👉 Discover more about the ARTIZEN Pivotal Trial of the Arcevo LSA device here: https://lnkd.in/eEr59kZF

Looking to increase process efficiency through API concentration strategies? Then join our upcoming webinar, "Enabling Higher Process Efficiency Through API Concentration Strategies," where Bachem experts Ivan Zemskov, Group Leader R&D, and Patrizia Marchetti, Senior Group Leader Technical Operations MPT, will share insights on how to: · Reduce isolation bottlenecks and increase efficiency through effective API concentration · Select the right concentration strategy for your peptide or oligonucleotide API · Apply molecule-tailored technologies and explore real-world, at-scale insights to optimize your manufacturing processes The session will also include a live Q&A, featuring Peter Mühlenbrock, Group Leader Technical Operations MPT, Valerio Ferlito, Process Specialist Technical Operations MPT, and Jakub Jagielski, Group Leader Oligo R&D. Save the Date: 20 October 2026, 5pm CEST Registration link: https://bit.ly/4x0V1BC #Bachem #Peptides #Oligonucleotides #Efficiency #Webinar

Kevin’s worsening symptoms led to an emergency visit to Advanced Cardiovascular Specialists (ACS), where it was determined that he needed a left ventricular assist device (LVAD). The device was placed by a medical team in Dallas, Texas. Throughout the challenging time, Kevin built a strong connection with the ACS team. Today, he is feeling better and grateful to spend time with his family. If you’re experiencing symptoms of heart failure, you don’t have to face them alone. Schedule an appointment today, and let our team walk this journey with you.

Medical device companies have spent decades improving the performance of their devices. The next competitive advantage may not come from the device alone; it may come from reducing uncertainty before it's ever implanted. Patient-specific planning data gives clinicians the ability to better understand anatomy, evaluate device fit, and prepare for procedural complexity before entering the operating room. The companies that invest in these digital capabilities won't just be delivering innovative devices. They'll be enabling more confident clinical decisions and more predictable procedures. As personalized medicine continues to evolve, that could become one of the biggest differentiators in cardiovascular care. #Cardiovascular #StructuralHeart #MedicalDevices #PatientSpecific #AI #SurgicalPlanning #MedTech

Join us at EACTS 2026 for our Lunch Symposium, "𝐄𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐢𝐧 𝐀𝐨𝐫𝐭𝐢𝐜 𝐀𝐫𝐜𝐡 𝐑𝐞𝐩𝐚𝐢𝐫," bringing together expert perspectives and innovative approaches to some of the challenges in aortic arch treatment. Moderated by Martin Czerny (Freiburg, Germany) and Tomas Holubec (Nürnberg, Germany), the symposium will feature expert perspectives on a range of innovative solutions and evolving treatment strategies, including AMDS™, Neo EDE™, the Nexus® Platform, and E-vita® Open Neo. Hear from Martin Czerny, Andrea Colli, Stuart Grant, Andreas Martens, and Petar Risteski as they share their experience, clinical insights, and perspectives on the evolving future of aortic arch repair. 📅 Thursday, October 8 🕛 12:15 PM - 1:30 PM 📍 Room 113 Save the date and add the symposium to your calendar: https://bit.ly/4AgSiag We look forward to seeing you at EACTS 2026! #Artivion #EACTS

𝗔𝘁𝘁𝗲𝗻𝗱𝗶 𝗶𝘀 𝗴𝗲𝘀𝘁𝗮𝗿𝘁 𝗺𝗲𝘁 𝗵𝗲𝘁 𝘁𝗿𝗮𝗷𝗲𝗰𝘁 𝗼𝗺 𝗱𝗲 𝗔𝘁𝘁𝗲𝗻𝗱𝗶 𝗔𝗽𝗽 𝘁𝗲 𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗲𝗿𝗲𝗻 𝗮𝗹𝘀 𝗺𝗲𝗱𝗶𝘀𝗰𝗵 𝗵𝘂𝗹𝗽𝗺𝗶𝗱𝗱𝗲𝗹, 𝗠𝗗𝗥 𝗞𝗹𝗮𝘀𝘀𝗲 𝗜𝗜𝗮. In de Ouderenzorg & Gehandicaptenzorg wordt volop geëxperimenteerd met AI, maar de kennis over wanneer de MDR van toepassing is, is nog beperkt. Ook wij leren hier elke week bij. Die lessen delen we in een vierdelige videoserie, zodat iedereen met ons mee kan leren. In de eerste video leggen we uit wat de MDR is, wat wij certificeren en waarom. Het volledige artikel over onze afwegingen, het traject en de tijdlijn lees je hier: https://lnkd.in/ecznvBxR Volg ons op LinkedIn om de komende maanden de videoserie te volgen. Vragen zijn welkom, waar mogelijk nemen we die mee in de volgende afleveringen.

Knowing your normal can help you notice when something changes. This Breast Cancer Awareness Month, Dr Hafsa Salim Daber, Specialist General & Laparoscopic Surgery at Aster Hospital, Qusais, walks you through 3 simple steps to help you become familiar with how your breasts normally look and feel, along with changes worth paying attention to. This is not a diagnostic test, but knowing what is normal for you can help you recognise changes and seek medical advice when needed. Make time for your breast health. Know your normal. Notice the change. Get it checked. #BreastCancerAwarenessMonth #BreastHealth #KnowYourNormal #WomensHealth #AsterHospital

Heb jij een afgeronde hbo-opleiding verpleegkunde, een geldige BIG-registratie en affiniteit met psychiatrie, LVB en/of forensische zorg? Solliciteer als verpleegkundige bij Beschermd Wonen+. Als verpleegkundige bij Beschermd Wonen+: ✅ Sta je stevig in je schoenen en combineer je medische deskundigheid met herstelgerichte begeleiding ✅ Kan je risico's risico's vroeg inschatten en werk je rustgevend in complexe situaties ✅ Stel je samen met je team en de cliënt behandeldoelen op, volgens de ART-methodiek ✅ Creëer je een veilig, stabiel leefklimaat gericht op herstel en zelfredzaamheid Interesse? Solliciteer direct!👉 Beschermd Wonen+. Werk met een +

See how your peers are taking a foundational approach to managing dry eyes with Blink® NutriTears®.

When patients have the right pharmacy partner, everyone benefits. Increased access, improved adherence, and coordinated care help create stronger outcomes for the communities we serve. That's why where you fill makes a difference.

Explore the clinical data behind Blink® NutriTears® and hear how it’s shaping your peers’ perspectives on nutritional supplements.

Artivion is Redefining possibilities at #EACTS! Two late-breaker podium presentations will spotlight AMDS™ and E-vita® Open Neo. 𝟐-𝐘𝐞𝐚𝐫 𝐀𝐨𝐫𝐭𝐢𝐜 𝐀𝐫𝐜𝐡 𝐑𝐞𝐦𝐨𝐝𝐞𝐥𝐢𝐧𝐠 𝐟𝐨𝐥𝐥𝐨𝐰𝐢𝐧𝐠 𝐈𝐦𝐩𝐥𝐚𝐧𝐭𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐀𝐌𝐃𝐒 𝐢𝐧 𝐀𝐜𝐮𝐭𝐞 𝐃𝐞𝐁𝐚𝐤𝐞𝐲 𝐓𝐲𝐩𝐞 𝐈 𝐃𝐢𝐬𝐬𝐞𝐜𝐭𝐢𝐨𝐧 - 𝐑𝐞𝐬𝐮𝐥𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐏𝐄𝐑𝐒𝐄𝐕𝐄𝐑𝐄 𝐒𝐭𝐮𝐝𝐲. 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐞𝐝 𝐛𝐲: 𝐃𝐫. 𝐒. 𝐅𝐮𝐤𝐮𝐡𝐚𝐫𝐚 (𝐔𝐧𝐢𝐭𝐞𝐝 𝐒𝐭𝐚𝐭𝐞𝐬) 🗓️ Friday, October 9th 📍 Late breaking clinical science 3 ⏰ 16:30 - 17:30 𝐄𝐚𝐫𝐥𝐲 𝐝𝐢𝐬𝐭𝐚𝐥 𝐟𝐚𝐥𝐬𝐞 𝐥𝐮𝐦𝐞𝐧 𝐬𝐭𝐚𝐭𝐮𝐬 𝐚𝐧𝐝 𝟐𝟒-𝐦𝐨𝐧𝐭𝐡 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐚𝐟𝐭𝐞𝐫 𝐄-𝐯𝐢𝐭𝐚 𝐎𝐏𝐄𝐍 𝐍𝐄𝐎 𝐫𝐞𝐩𝐚𝐢𝐫 𝐟𝐨𝐫 𝐚𝐨𝐫𝐭𝐢𝐜 𝐝𝐢𝐬𝐬𝐞𝐜𝐭𝐢𝐨𝐧. 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐞𝐝 𝐛𝐲: 𝐏𝐫𝐨𝐟. 𝐑. 𝐖𝐨𝐧𝐠 (𝐇𝐨𝐧𝐠 𝐊𝐨𝐧𝐠) 🗓️ Friday, October 9th 📍 Late breaking clinical science 3 ⏰ 16:30 - 17:30 Learn more about our activities at EACTS by visiting: https://bit.ly/4rxtDtV #Artivion #aorticarch

𝗥𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲. 𝗥𝗲𝗮𝗹 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗽𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲. 𝗦𝘂𝗻𝗶𝗿 𝗚𝗮𝗿𝗴, 𝗠𝗗, a retina specialist for over 20 years, shares his perspective on using Bi-Blade™+ dual-port vitrectomy cutters in vitreoretinal surgery. With cutting speeds up to 25,000 cuts per minute, Bi-Blade+ delivers: • Improved flow rate for more efficient vitreous removal • Reduced retinal traction and cutter vibration • Greater surgical stability and control #BauschSurgical #BiBladePlus #RetinaSurgery #Vitrectomy

Este fin de semana hemos celebrado la segunda edición de #ARISTEIA, una iniciativa impulsada por argenx para fomentar el diálogo científico y el intercambio de experiencias en el ámbito de las enfermedades neuromusculares, con el objetivo de seguir avanzando en la excelencia asistencial y en una atención cada vez más personalizada para los pacientes. Durante estas jornadas, más de 120 especialistas de España y Portugal compartieron experiencias, debatieron sobre los retos actuales de la práctica clínica y analizaron los últimos avances científicos en un entorno de aprendizaje colaborativo. Esta segunda edición ha contado con la valiosa participación de un comité científico, integrado por Dra. Elena Cortés, Dr. Luis Querol, Dr. Miguel Oliveira Santos cuyo conocimiento y compromiso han sido fundamentales para impulsar un debate de alto nivel científico y generar un intercambio enriquecedor entre todos los asistentes. El encuentro contó además con la participación de Tim Van Hauwermeiren, fundador y presidente del Consejo de Administración de argenx, quien tuvo la oportunidad de conocer de primera mano las reflexiones y prioridades de la comunidad científica, así como reafirmar el compromiso de la compañía con la escucha activa y la colaboración con todos los implicados en el manejo de estas enfermedades. ARISTEIA refleja el compromiso de argenx con la generación de conocimiento científico y la promoción de espacios de colaboración que contribuyan a seguir avanzando en la atención de las personas que viven con enfermedades neuromusculares para mejorar su calidad de vida. 🎥 ¡Os invitamos a conocer un poco más sobre Aristeia en el siguiente vídeo! #TogetherWeDiscover #Aristeia2026

Este fim de semana realizámos a segunda edição do #ARISTEIA, uma iniciativa promovida pela argenx para fomentar o diálogo científico e a partilha de experiências no âmbito das doenças neuromusculares, com o objetivo de continuar a avançar na excelência dos cuidados de saúde e numa atenção cada vez mais personalizada aos doentes. Durante estas jornadas, mais de 120 especialistas de Espanha e Portugal partilharam experiências, debateram os desafios atuais da prática clínica e analisaram os mais recentes avanços científicos num ambiente de aprendizagem colaborativa. Esta segunda edição contou com a valiosa participação de um comité científico, composto pela Dra. Elena, pelo Dr. Luis Querol e pelo Dr. Miguel Oliveira Santos, neurologistas especializados em doenças neuromusculares, cujo conhecimento e empenho foram fundamentais para promover um debate de elevado nível científico e gerar uma troca enriquecedora entre todos os participantes. O encontro contou ainda com a participação de Tim Van Hauwermeiren, fundador e presidente do Conselho de Administração da argenx, que teve a oportunidade de conhecer em primeira mão as reflexões e prioridades da comunidade científica, bem como de reafirmar o compromisso da empresa com a escuta ativa e a colaboração com todos os envolvidos no tratamento destas doenças. A ARISTEIA reflete o compromisso da argenx com a geração de conhecimento científico e a promoção de espaços de colaboração que contribuam para continuar a avançar na prestação de cuidados às pessoas que vivem com doenças neuromusculares, com vista a melhorar a sua qualidade de vida. 🎥 Convidamo-vos a conhecer um pouco mais sobre a Aristeia no vídeo seguinte! #TogetherWeDiscover #Aristeia2026

📢 Big news, Appoyo fam! 🎉 Tired of juggling 4 different systems to run your NDIS business? We hear you! That's why we're going LIVE with FREE webinars to show you how our 4-in-1 AI care platform brings rostering, HR, payroll, facilities & incident management into ONE place. ✨ 🗓️ Every Tuesday & Thursday @ 1PM 🎯 Module-by-module walkthroughs Hosted by our amazing Head of Customer Success, Simone! 💜 #Appoyo #NDIS #AgedCare #DisabilitySupport #CareProviders

🚀 Multiple systems for HR, rostering, care, incidents and payroll can mean more admin, more manual work and more room for error. Appoyo brings it all together. One platform. One login. Complete visibility across your business. 🙌 Less complexity. Lower costs. More time to focus on sustainable growth. 👉 Ready to simplify your business? Book a demo today. #Appoyo #NDISProviders #CareManagement #BusinessGrowth #Automation

Great insights from Margaret Blackwell, Global Talent Acquisition & Recruiting Services at Amplity, during a recent webinar with BioSpace. As generational shifts reshape the workforce and skills-based hiring gains momentum, life sciences companies are rethinking how they attract top talent. Hear her perspective on finding the right talent across four generations of workers. 🎥 Watch now. #AmplityRecruiting #LifeSciencesRecruiting

Madrid, here we come. 🚀🚀 From 6 to 8 October, Agronova Biotech will be at Fruit Attraction 2026, at IFEMA Madrid. Fruit Attraction is one of the largest international trade fairs dedicated to the fruit and vegetable sector — three days when Madrid becomes the meeting point for the entire fruit and vegetable value chain, from new technologies to solutions making their way to the field and the market. 📍 IFEMA – Madrid 📅 6 – 8 October 📌 STAND 7C25 One month to go. Until then, stay tuned. 👀 [ES] Madrid, allá vamos. 🚀🚀 Del 6 al 8 de octubre, Agronova Biotech estará en Fruit Attraction 2026, en IFEMA Madrid. Fruit Attraction es una de las mayores ferias internacionales dedicadas al sector hortofrutícola — tres días en los que Madrid se convierte en el punto de encuentro de toda la cadena de valor de frutas y hortalizas, desde las nuevas tecnologías hasta las soluciones que están llegando al campo y al mercado. 📍 IFEMA – Madrid 📅 6 – 8 de octubre 📌 STAND 7C25 Falta un mes. Hasta entonces, mantente atento. 👀

Supporting our partners starts with creating the right environment for our teams. ALPS China has recently moved into a new office designed to enhance collaboration, support daily operations, and strengthen connections across the area. A practical change that helps us work more effectively and continue providing responsive support to the O&P community. Making Lives Better.